Sotera Health Company updated revenue guidance for the full-year 2021. For the period, The company expects full-year 2021 revenues to be at the high-end of previously communicated guidance range of $920 million to $930 million. This represents full-year total revenue growth of approximately 14% compared to the prior year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 USD | +3.49% |
|
+14.30% | -20.77% |
07-01 | Sotera Health Company(NasdaqGS:SHC) dropped from Russell Midcap Growth Index | CI |
07-01 | Sotera Health Company(NasdaqGS:SHC) dropped from Russell 3000E Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.77% | 3.78B | |
+19.32% | 84.59B | |
-21.99% | 77.33B | |
+0.92% | 27.12B | |
-5.06% | 18.19B | |
+7.91% | 18.49B | |
+7.69% | 16.49B | |
+76.20% | 13.55B | |
+76.56% | 13.03B | |
-27.72% | 12.43B |
- Stock Market
- Equities
- SHC Stock
- News Sotera Health Company
- Sotera Health Company Updates Revenue Guidance for the Full-Year 2021